UK markets open in 4 hours 16 minutes
NIKKEI 225
38,108.80 -296.86 (-0.77%) HANG SENG
17,763.03 +16.12 (+0.09%) CRUDE OIL
81.10 -0.83 (-1.01%) GOLD FUTURES
2,297.40 -5.50 (-0.24%) DOW
37,815.92 -570.17 (-1.49%) Bitcoin GBP
47,938.62 -3,152.27 (-6.17%)
Atara Biotherapeutics, Inc. (ATRA)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 85.25M |
| Enterprise value | 91.39M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 8.82 |
| Price/book (mrq) | N/A |
| Enterprise value/revenue | 10.66 |
| Enterprise value/EBITDA | -0.34 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.72 |
| 52-week change 3 | -74.44% |
| S&P500 52-week change 3 | 23.10% |
| 52-week high 3 | 3.0150 |
| 52-week low 3 | 0.1990 |
| 50-day moving average 3 | 0.7147 |
| 200-day moving average 3 | 1.0656 |
Share statistics
| Avg vol (3-month) 3 | 2.6M |
| Avg vol (10-day) 3 | 877.76k |
| Shares outstanding 5 | 119.36M |
| Implied shares outstanding 6 | 119.36M |
| Float 8 | 90.82M |
| % held by insiders 1 | 2.77% |
| % held by institutions 1 | 60.35% |
| Shares short (15 Apr 2024) 4 | 11.45M |
| Short ratio (15 Apr 2024) 4 | 9.11 |
| Short % of float (15 Apr 2024) 4 | 9.80% |
| Short % of shares outstanding (15 Apr 2024) 4 | 9.59% |
| Shares short (prior month 15 Mar 2024) 4 | 11.03M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -1,922.44% |
Management effectiveness
| Return on assets (ttm) | -62.11% |
| Return on equity (ttm) | -2,014.86% |
Income statement
| Revenue (ttm) | 8.57M |
| Revenue per share (ttm) | 0.08 |
| Quarterly revenue growth (yoy) | 1,345.70% |
| Gross profit (ttm) | N/A |
| EBITDA | -264.45M |
| Net income avi to common (ttm) | -276.13M |
| Diluted EPS (ttm) | -2.6100 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 51.73M |
| Total cash per share (mrq) | 0.43 |
| Total debt (mrq) | 60.49M |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 0.72 |
| Book value per share (mrq) | -0.93 |
Cash flow statement
| Operating cash flow (ttm) | -192.98M |
| Levered free cash flow (ttm) | -55.72M |
© 2024 Yahoo. All rights reserved.